Pulmonary immaturity and the accompanying lack of surfactant results in hyaline membrane disease, a major factor in morbidity and mortality associated with premature birth. This disorder is related to lack of synthesis and secretion of lamellar bodies from Type II cells. Proposed research will seek to characterize molecular and humoral mechanisms controlling synthesis and release of surfactant from rat Type II cells in culture. The proposal is based on the hypothesis that catecholamine dependent surfactant release is mediated by activation of c-AMP protein kinase and subsequent protein phosphorylation, enhancing synthesis, processing and secretion of lamellar bodies. We will test whether the dramatic ontogenic appearance of surfactant release prior to birth is related to synthesis of developmentally and humorally regulated cellular components which mediate surfactant synthesis and secretion. Two major areas of work are proposed. The first seeks to associate activation of c-AMP and Ca2+ dependent protein kinases, specific protein phosphorylation (in 32P-phosphate labelled Type II cells) and secretogogue dependent apoprotein and phospholipid secretion from Type II cells. Developmental aspects of the c-AMP surfactant release system will be assessed in fetal Type II epithelial cells. The second area of proposed work will use polyclonal and monoclonal antibodies prepared for surfactant associated apoprotein to characterize synthesis, intracellular processing and secretion of apoprotein (A). Factors controlling the developmental appearance of apoprotein will be determined during late gestation. Molecular characteristics of apoprotein, rates of synthesis and processing (proteolysis, glycosylation and association with phospholipid) will be assessed using pulse-chase techniques after labelling with (35S) methionine, (3H) leucine, (14C) carbohydrates and (3H)choline. Ontogenic regulation of synthesis and processing will be determined in association with phospholipid synthesis and appearance of lamellar bodies. Purification and translation of apoprotein (A) mRNA will be assessed to determine whether developmental appearance of apoprotein (A) production is controlled at transcriptional, translational or post-translational levels. cDNA probes will be prepared to determine gene and protein sequence and to assess regulatory aspects of apo A synthesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL028623-09
Application #
3339975
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Project Start
1982-03-01
Project End
1995-02-28
Budget Start
1990-03-01
Budget End
1991-02-28
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Trapnell, Bruce C; Whitsett, Jeffrey A; Nakata, Koh (2003) Pulmonary alveolar proteinosis. N Engl J Med 349:2527-39
Quintero, Omar A; Korfhagen, Thomas R; Wright, Jo Rae (2002) Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Physiol 283:L76-85
Trapnell, Bruce C; Whitsett, Jeffrey A (2002) Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775-802
Yoshida, M; Ikegami, M; Reed, J A et al. (2001) GM-CSF regulates protein and lipid catabolism by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 280:L379-86
Hayashida, S; Harrod, K S; Whitsett, J A (2000) Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo. Am J Physiol Lung Cell Mol Physiol 279:L452-9
Borron, P; McIntosh, J C; Korfhagen, T R et al. (2000) Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 278:L840-7
Fisher, J H; Sheftelyevich, V; Ho, Y S et al. (2000) Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol 278:L365-73
Bruno, M D; Korfhagen, T R; Liu, C et al. (2000) GATA-6 activates transcription of surfactant protein A. J Biol Chem 275:1043-9
Ikegami, M; Whitsett, J A; Chroneos, Z C et al. (2000) IL-4 increases surfactant and regulates metabolism in vivo. Am J Physiol Lung Cell Mol Physiol 278:L75-80
Ikegami, M; Harrod, K S; Whitsett, J A et al. (1999) CCSP deficiency does not alter surfactant homeostasis during adenoviral infection. Am J Physiol 277:L983-7

Showing the most recent 10 out of 75 publications